Navigation Links
Stronger Backing for Drug-Coated Stents

New research proves drug-coated stents effectively combat death, heart attack and repeat procedures in the real world.//

A new study from researchers in the Netherlands indicates that patients in clinical trials of drug-coated stents represented a very select group of the total population. This new study takes a closer look at the effects of drug-coated stents on real-world patients, patients the researchers say tend to be older and sicker than those selected for clinical trials.

The study included more than 500 patients with previously untreated blocked arteries who were treated with drug-eluting stents. An additional 450 patients with comparable blockages were treated with bare metal stents. Sixty-eight percent of the patients in this trial did not meet the selection criteria of previous clinical trials.

Results of the one-year study show 9.7 percent of patients who received drug-eluting stents had a major adverse cardiac event, compared with 14.8 percent of patients treated with bare metal stents. Only 3.7 percent of patients with drug-eluting stents experienced renarrowing of the treated vessel, a common complication that leads to corrective procedures. However, 10.9 percent of patients with bare metal stents required repeat procedures to correct renarrowing of the artery.

Lead investigator Patrick W. Serruys, M.D., Ph.D., from Erasmus Medical Center in the Netherlands, says, “The treatment effects -- particularly the reduction of re-interventions -- were similar across very different subgroups of patients.” He says drug-eluting stents are the next major step in interventional cardiology.

In an accompanying editorial, David P. Fason, M.D., from the University of Chicago, says the research results “go a long way in re-assuring the practitioner that drug-eluting stents are in fact safe and effective in a wide variety of patients undergoing ‘real world’ angioplasty.” He concludes that the next step shoul
'"/>




Page: 1 2

Related medicine news :

1. Health Care Ties To Get Stronger Between India And Britain
2. Women Portray Stronger Immune Response As Compared to Men, Study Suggests
3. Stronger Doses Fewer Administration for Breast Cancer
4. Stronger Quadricep Controls Knee Osteoarthritis
5. Old Indian Advice Has A Scientific Backing Now!
6. Fury over Backing of Health Shake-up
7. Failure of Drug-Coated Stent
8. Drug-Coated Stent
9. Drug-Coated Stents – Proven to be More Effectiv
10. Drug-Coated Stents Work Better In Diabetic Patients After Angioplasty
11. Drug-Coated Stents – Proven to be More Effectiv

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Stronger Backing for Drug Coated Stents

(Date:11/25/2009)...ncer who were treated with cisplatin-based chemoth...ological side effects and Raynaud-like phenomena, ...ccording to a new study published online November ...e . , Marianne Brydy, M.D., of the Department of...n, Norway, and colleagues conducted a cross-sectio...
(Date:11/25/2009)...rt to draw definite conclusions, experts say, , ...In diabetic patients with blocked coronary arterie...t one year whether patients undergo bypass surgery... report. , Bypass surgery has been the standard...ery disease. However, less invasive approaches suc...
(Date:11/25/2009)...l symptoms, study finds , , WEDNESDAY, ...cts are among the potential problems faced by long...ted with cisplatin-based chemotherapy, a new study...n men treated for unilateral testicular cancer bet...rvey conducted from 1998 to 2002. , The researc...
(Date:11/25/2009)...4thStraightYear ,, WASHINGTON,Nov.25/PRNewswi...(LCA-GA)issuedthe 4thAnnualReportCardonLungCancer ...tthislethaldiseaseinthestateofGeorgia.LCA-GAisacha...izationdedicatedexclusivelytopatientsupportandadvo..., (Logo: http://www.newscom.com/cgi-bin/prnh/20081...
(Date:11/25/2009)...ill tumor cells, study finds , , WEDNESD...elivered in a fingernail-size implant eliminated m...The method uses polymer disks, 8.5 millimeters in ...gens and implanted under the skin to reprogram the...rsity scientists who developed the implant predict...
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2
...he young and fair skinned tan lovers should give s...ce the development of skin cancer, the European Co...ve arm of the European Union said that its scienti...in cancer. European Commission spokesman Greg...
...latant and unwholesome food marketing is on the ri...obesity. It is evident that food marketing impacts...tary pattern and food habits that can last a lifet...food advertisements on dietary choice. They have p...
...olice today, had seized a large quantity of spurio...n for possession of drugs having fake labels of co...p-off, a police team raided a drug store in Leader...whose genuine versions would have been worth Rs 15...
...anofi Pasteur, the world's third-largest pharmaceu...y have reached an initial agreement to conduct joi...used on humans early next year.// According to...ths to 18 years owing to the increased susceptibil...
...he U.S. Food and Drug Administration has approved ...ment for multiple myeloma, which is a type of bloo...rug will now be able to market Revlimid for use in...earlier been treated with chemotherapy. The ...
...he central government Thursday assured the Delhi H...te of Medical Sciences (AIIMS) director P. Venugop...etition. Additional Solicitor General Gopal S...ng upon the AIIMS governing body's recommendation ...
Other Medicine News:Health News:Agreement for Joint Trials of Avian Flu Vac cine on Humans 2Health News:Venugopal will not be Sacked Before Court Verdict: Central Government 2
(Date:11/25/2009)...re/--TheFDAgrantedtraditionalapprovalforINTELENCE&...nscriptaseinhibitor(NNRTI).INTELENCEistheonlyNNRTI...adultswhoareexperiencingvirologicfailurewithHIV-1s...)agents.Thetraditionalapprovalisbasedon48-weekdata...CEiscurrentlymarketedintheU.S.byTibotecTherapeutic...
(Date:11/25/2009)...ire/--RegadoBiosciences,aprivatelyheldcompanyleadi...controlagents,announcedthatDavidMazzo,PhD,CEOandPr...lHealthCareConferenceattheNewYorkPalaceHotelinNewY...EST)onTuesday,December1andwillincludeanoverviewoft...tprogram,theanticoagulantsystem,REG1.Thehealthcare...
(Date:11/25/2009)...re-FirstCall/--Abaxis,Inc.(Nasdaq: ABAX ),amedical...ysissystems,announcedtodaythatClintSeverson,chairm...ualPiperJaffrayHealthCareConferenceonWednesday,Dec...heNewYorkPalaceHotelinNewYorkCity. ,, AboutAba...rtablebloodanalysissystemsforuseinanyveterinaryorh...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Identafi 28TM 29 3000 Picked by Dentistry Today Magazine as One of the Top 100 Products of 2009 50599 1Identafi 28TM 29 3000 Picked by Dentistry Today Magazine as One of the Top 100 Products of 2009 50599 2Jury Convicts Los Angeles Physician Assistant for Stealing Doctors Identity and Defrauding Medicare in 247 7 Million Scheme 50595 1Jury Convicts Los Angeles Physician Assistant for Stealing Doctors Identity and Defrauding Medicare in 247 7 Million Scheme 50595 2Jury Convicts Los Angeles Physician Assistant for Stealing Doctors Identity and Defrauding Medicare in 247 7 Million Scheme 50595 3Jury Convicts Los Angeles Physician Assistant for Stealing Doctors Identity and Defrauding Medicare in 247 7 Million Scheme 50595 4Growth Hormone May Build Muscle in Older Men 50591 1Growth Hormone May Build Muscle in Older Men 50591 2
...arch 11 InteKrin Therapeutics, Inc., a clinical s..., metabolism and obesity, today announced it has c...y of INT131, a novel, non-TZD selective modulator ... diabetes (T2DM). INT131-007 is a 24 week, high d...controlled study of INT131 at four doses in poorly...
...h 10 BioSpecifics Technologies Corp. (Nasdaq: B...t in class collagenase-based products, today annou...l present a corporate overview at the upcoming Cow...on Tuesday, March 17, 2009, at 9:30am ET at the Bo...ebcast of the presentation can be accessed at www...
Other Medicine Technology:InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study 2
Neumann Tying Forceps - Straight
Neumann Tying Forceps - Angled
Shepard Straight Tying Forceps
Shepard Curved Tying Forceps
Medicine Products: